Lightfoot R W
J Rheumatol Suppl. 1980;6:61-7.
Six centers participated in a double-blind crossover study in patients with rheumatoid arthritis (RA) and osteoarthritis to evaluate the most advantageous timing of the daily dose of benoxaprofen. The study results revealed no significant difference between the morning and evening dose administered at a daily dose of 600 mg; however, more patients with RA preferred the evening dose.
六个中心参与了一项针对类风湿性关节炎（RA）和骨关节炎患者的双盲交叉研究，以评估每日服用贝诺洛芬剂量的最有利时间。研究结果显示，每日剂量为600毫克时，早晨服药和晚上服药之间没有显著差异；然而，更多的类风湿性关节炎患者更喜欢晚上服药。
